New Life Medical Group (formerly Tennessee Hyperbaric Center/Pain Specialist Center), does not accept the idea that nothing else can be done. Your body is the most remarkable thing in all of creation, and NLMG is finding innovative ways that your body can work to heal itself. Good doctors treat a symptom and seek to find solutions to your concerns and pains. Great doctors and practices go a step beyond the traditional roles; NLMG seeks to bring hope to your life, vibrancy to your day and dreams to your restful nights.
Dr. Schmidt is a Board Certified anesthesiologist and completed training at the Cleveland Clinic and Baystate Medical Center, affiliated with Tufts University. He received his Doctor of Medicine from Loma Linda University in Loma Linda, Calif. He completed his Bachelor of Science in Biochemistry at Andrews University in Berrien Springs, Mich. His certifications include ASIIP accreditation in opiod administration and coding, suboxone detoxification accreditation, advanced training in implantable devices (spinal cord stimulation and intrathecal pumps), stem cell therapy and hyperbaric medicine. He is a member of the American Society of Interventional Pain Physicians, the American Association of Orthopaedic Medicine (AAOM), the North American Neuromodulation Society, the American College of Hyperbaric Medicine and the International Hyperbaric Medicine Society.
Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 patients with respiratory distress.
Amidst a global COVID-19 crisis, immunity is on our mind.
The obvious strategy is to directly administer glutathione. This can be done orally, topically, intravenously, intranasally, or in nebulized form. Glutathione administered intravenously, inhaled, and ingested intranasally increases systemic levels. Glutathione has a short half-life but has shown at least short-term efficacy in several diseases.
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.